

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.17955558 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.17955558 |
| 3 | positive regulation of histone deacetylation (GO:0031065) | 3.92797318 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.59534147 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.48579793 |
| 6 | positive thymic T cell selection (GO:0045059) | 3.47199298 |
| 7 | regulation of ARF GTPase activity (GO:0032312) | 3.41815944 |
| 8 | regulation of ARF protein signal transduction (GO:0032012) | 3.40378245 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.35112730 |
| 10 | protein localization to endosome (GO:0036010) | 3.35010419 |
| 11 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.34329344 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.32909491 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.32909491 |
| 14 | sodium ion export (GO:0071436) | 3.30754197 |
| 15 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.29576613 |
| 16 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.29434502 |
| 17 | positive regulation of Rap GTPase activity (GO:0032854) | 3.28321463 |
| 18 | stress fiber assembly (GO:0043149) | 3.18710829 |
| 19 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.10667965 |
| 20 | negative regulation of cell size (GO:0045792) | 3.09864873 |
| 21 | mannose metabolic process (GO:0006013) | 3.04957536 |
| 22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.04721032 |
| 23 | response to peptidoglycan (GO:0032494) | 3.01066580 |
| 24 | locomotory exploration behavior (GO:0035641) | 2.99682015 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 2.98737890 |
| 26 | peptidyl-lysine dimethylation (GO:0018027) | 2.92847116 |
| 27 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.87234578 |
| 28 | activation of protein kinase A activity (GO:0034199) | 2.87029680 |
| 29 | regulation of Rap GTPase activity (GO:0032317) | 2.85383533 |
| 30 | positive regulation of receptor recycling (GO:0001921) | 2.84879762 |
| 31 | cortical actin cytoskeleton organization (GO:0030866) | 2.84587926 |
| 32 | synaptic vesicle maturation (GO:0016188) | 2.84423368 |
| 33 | response to muramyl dipeptide (GO:0032495) | 2.83960831 |
| 34 | thymic T cell selection (GO:0045061) | 2.83085857 |
| 35 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.82635854 |
| 36 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.79094032 |
| 37 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.79083618 |
| 38 | endothelial cell chemotaxis (GO:0035767) | 2.78475210 |
| 39 | positive regulation of protein deacetylation (GO:0090312) | 2.77520799 |
| 40 | germinal center formation (GO:0002467) | 2.75883172 |
| 41 | apoptotic cell clearance (GO:0043277) | 2.71093251 |
| 42 | regulation of early endosome to late endosome transport (GO:2000641) | 2.70842053 |
| 43 | regulation of leukocyte degranulation (GO:0043300) | 2.70669782 |
| 44 | apoptotic process involved in morphogenesis (GO:0060561) | 2.68254358 |
| 45 | detection of other organism (GO:0098543) | 2.68099735 |
| 46 | plasma membrane repair (GO:0001778) | 2.68084360 |
| 47 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.67537438 |
| 48 | cell-cell junction maintenance (GO:0045217) | 2.67360394 |
| 49 | detection of bacterium (GO:0016045) | 2.66881635 |
| 50 | activation of JUN kinase activity (GO:0007257) | 2.65821336 |
| 51 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.64367466 |
| 52 | adenosine receptor signaling pathway (GO:0001973) | 2.64026726 |
| 53 | regulation of synapse structural plasticity (GO:0051823) | 2.63220239 |
| 54 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.60542491 |
| 55 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.60066482 |
| 56 | positive regulation of protein dephosphorylation (GO:0035307) | 2.59894330 |
| 57 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.58146350 |
| 58 | regulation of p38MAPK cascade (GO:1900744) | 2.56570293 |
| 59 | positive T cell selection (GO:0043368) | 2.56047251 |
| 60 | adherens junction assembly (GO:0034333) | 2.54921783 |
| 61 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.53044686 |
| 62 | semaphorin-plexin signaling pathway (GO:0071526) | 2.49113899 |
| 63 | angiogenesis involved in wound healing (GO:0060055) | 2.47829155 |
| 64 | modulation by symbiont of host cellular process (GO:0044068) | 2.46866038 |
| 65 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.45628524 |
| 66 | response to laminar fluid shear stress (GO:0034616) | 2.45626195 |
| 67 | cell-substrate adherens junction assembly (GO:0007045) | 2.44683472 |
| 68 | focal adhesion assembly (GO:0048041) | 2.44683472 |
| 69 | cell-substrate junction assembly (GO:0007044) | 2.44573308 |
| 70 | regulation of extracellular matrix disassembly (GO:0010715) | 2.44553674 |
| 71 | negative thymic T cell selection (GO:0045060) | 2.43135618 |
| 72 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.43085522 |
| 73 | activation of MAPKKK activity (GO:0000185) | 2.42008381 |
| 74 | regulation of mast cell degranulation (GO:0043304) | 2.41661256 |
| 75 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.41523498 |
| 76 | NIK/NF-kappaB signaling (GO:0038061) | 2.40372304 |
| 77 | megakaryocyte development (GO:0035855) | 2.38478628 |
| 78 | regulation of necroptotic process (GO:0060544) | 2.38470413 |
| 79 | macrophage activation involved in immune response (GO:0002281) | 2.38443128 |
| 80 | clathrin coat assembly (GO:0048268) | 2.37584916 |
| 81 | detection of external biotic stimulus (GO:0098581) | 2.37517786 |
| 82 | T cell selection (GO:0045058) | 2.37440629 |
| 83 | positive regulation of fibroblast migration (GO:0010763) | 2.35942913 |
| 84 | B cell receptor signaling pathway (GO:0050853) | 2.35164887 |
| 85 | leukocyte aggregation (GO:0070486) | 2.34827343 |
| 86 | positive regulation of B cell differentiation (GO:0045579) | 2.33827431 |
| 87 | mature B cell differentiation (GO:0002335) | 2.33696743 |
| 88 | cell communication by electrical coupling (GO:0010644) | 2.33509341 |
| 89 | negative regulation of myotube differentiation (GO:0010832) | 2.33284886 |
| 90 | coronary vasculature morphogenesis (GO:0060977) | 2.32834312 |
| 91 | regulation of regulated secretory pathway (GO:1903305) | 2.32313873 |
| 92 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.31952398 |
| 93 | cortical cytoskeleton organization (GO:0030865) | 2.31745533 |
| 94 | neutrophil activation involved in immune response (GO:0002283) | 2.31485298 |
| 95 | response to fluid shear stress (GO:0034405) | 2.31218079 |
| 96 | pre-miRNA processing (GO:0031054) | 2.31167958 |
| 97 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.31149386 |
| 98 | natural killer cell differentiation (GO:0001779) | 2.29905686 |
| 99 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.29550278 |
| 100 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.28286969 |
| 101 | layer formation in cerebral cortex (GO:0021819) | 2.27929776 |
| 102 | negative T cell selection (GO:0043383) | 2.26932330 |
| 103 | modulation by virus of host process (GO:0019054) | 2.26838477 |
| 104 | negative regulation of granulocyte differentiation (GO:0030853) | 2.26753231 |
| 105 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.26716774 |
| 106 | potassium ion import (GO:0010107) | 2.26319432 |
| 107 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.25283325 |
| 108 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.25097779 |
| 109 | negative regulation of interleukin-12 production (GO:0032695) | 2.25049821 |
| 110 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.24833912 |
| 111 | atrioventricular valve morphogenesis (GO:0003181) | 2.23734530 |
| 112 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.23378800 |
| 113 | detection of molecule of bacterial origin (GO:0032490) | 2.22965611 |
| 114 | activation of Rac GTPase activity (GO:0032863) | 2.22404581 |
| 115 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.21018957 |
| 116 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.20999446 |
| 117 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.20469167 |
| 118 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.20197793 |
| 119 | signal complex assembly (GO:0007172) | 2.19977948 |
| 120 | adaptation of signaling pathway (GO:0023058) | 2.18239895 |
| 121 | negative regulation of type 2 immune response (GO:0002829) | 2.18204086 |
| 122 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.18093618 |
| 123 | regulation of necrotic cell death (GO:0010939) | 2.17991334 |
| 124 | NLS-bearing protein import into nucleus (GO:0006607) | 2.17564535 |
| 125 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.17348105 |
| 126 | negative regulation of heart growth (GO:0061117) | 2.17348105 |
| 127 | pinocytosis (GO:0006907) | 2.16999082 |
| 128 | cell volume homeostasis (GO:0006884) | 2.16596383 |
| 129 | cAMP biosynthetic process (GO:0006171) | 2.16240836 |
| 130 | receptor catabolic process (GO:0032801) | 2.16155335 |
| 131 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.16112402 |
| 132 | regulation of macrophage cytokine production (GO:0010935) | 2.15837884 |
| 133 | barbed-end actin filament capping (GO:0051016) | 2.15799097 |
| 134 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.15381954 |
| 135 | cellular potassium ion homeostasis (GO:0030007) | 2.15362304 |
| 136 | regulation of lipid kinase activity (GO:0043550) | 2.15218690 |
| 137 | establishment of protein localization to Golgi (GO:0072600) | 2.14954142 |
| 138 | positive regulation of p38MAPK cascade (GO:1900745) | 2.14519047 |
| 139 | cardiac myofibril assembly (GO:0055003) | 2.13576448 |
| 140 | positive regulation by symbiont of host defense response (GO:0052509) | 2.13527757 |
| 141 | modulation by symbiont of host defense response (GO:0052031) | 2.13527757 |
| 142 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.13527757 |
| 143 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.13527757 |
| 144 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.13527757 |
| 145 | modulation by symbiont of host immune response (GO:0052553) | 2.13527757 |
| 146 | regulation of type 2 immune response (GO:0002828) | 2.13356065 |
| 147 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.13164117 |
| 148 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.13088520 |
| 149 | negative regulation of necroptotic process (GO:0060546) | 2.11251788 |
| 150 | positive regulation of myotube differentiation (GO:0010831) | 2.08826403 |
| 151 | negative regulation of fatty acid transport (GO:2000192) | 2.08594575 |
| 152 | protein targeting to plasma membrane (GO:0072661) | 2.08254370 |
| 153 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.07883428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.37167359 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.15809949 |
| 3 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 3.08164867 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.97512103 |
| 5 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.88027998 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.78920670 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.78297901 |
| 8 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.72278326 |
| 9 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.57506536 |
| 10 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.50454604 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.38131615 |
| 12 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.37934264 |
| 13 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.37714537 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.09591544 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.05710597 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.03701079 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.03361436 |
| 18 | * KDM2B_26808549_Chip-Seq_K562_Human | 2.02782096 |
| 19 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 2.01471470 |
| 20 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.96764371 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.93758318 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 1.92176671 |
| 23 | UTX_26944678_Chip-Seq_JUKART_Human | 1.84813290 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.82105263 |
| 25 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.79949823 |
| 26 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.79864264 |
| 27 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.71717606 |
| 28 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.71567494 |
| 29 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.69811330 |
| 30 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.69548324 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.67275089 |
| 32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.65531360 |
| 33 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.65157137 |
| 34 | GATA1_19941826_ChIP-Seq_K562_Human | 1.62043808 |
| 35 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.61781500 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59070453 |
| 37 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.58433865 |
| 38 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.54961008 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.54956784 |
| 40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.54921670 |
| 41 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.54691320 |
| 42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.54454534 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.54100297 |
| 44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53456620 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.52514072 |
| 46 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.52283294 |
| 47 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.50843707 |
| 48 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.50573599 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.49956364 |
| 50 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.49942090 |
| 51 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.49844372 |
| 52 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.49080249 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.49075349 |
| 54 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48723765 |
| 55 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.47637515 |
| 56 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.46039939 |
| 57 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.44539340 |
| 58 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.44467647 |
| 59 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.43519758 |
| 60 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.42646299 |
| 61 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.40109868 |
| 62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37831712 |
| 63 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34192994 |
| 64 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.33553156 |
| 65 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.31770183 |
| 66 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.30539586 |
| 67 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.28685894 |
| 68 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.27716392 |
| 69 | P68_20966046_ChIP-Seq_HELA_Human | 1.27492260 |
| 70 | * MAF_26560356_Chip-Seq_TH2_Human | 1.27377653 |
| 71 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.27325987 |
| 72 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.25046013 |
| 73 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.24942940 |
| 74 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.24790156 |
| 75 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22392234 |
| 76 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21379518 |
| 77 | MYB_26560356_Chip-Seq_TH1_Human | 1.20968454 |
| 78 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.20941908 |
| 79 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.20699518 |
| 80 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.20537626 |
| 81 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.17448056 |
| 82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17071601 |
| 83 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16500407 |
| 84 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.16381066 |
| 85 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.16381066 |
| 86 | MYB_26560356_Chip-Seq_TH2_Human | 1.15582389 |
| 87 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.15505951 |
| 88 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.15260405 |
| 89 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14677634 |
| 90 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.13424270 |
| 91 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.12460966 |
| 92 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.12285796 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11392789 |
| 94 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10938899 |
| 95 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.10006038 |
| 96 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.09502105 |
| 97 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.09479409 |
| 98 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09397280 |
| 99 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.09185497 |
| 100 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.09036905 |
| 101 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08200704 |
| 102 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.07370311 |
| 103 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.07330577 |
| 104 | GATA2_19941826_ChIP-Seq_K562_Human | 1.06825391 |
| 105 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06649391 |
| 106 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05953250 |
| 107 | ATF3_27146783_Chip-Seq_COLON_Human | 1.04494328 |
| 108 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.02420058 |
| 109 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01657735 |
| 110 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01656571 |
| 111 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.01330665 |
| 112 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.01068904 |
| 113 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.00257676 |
| 114 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99521248 |
| 115 | SA1_27219007_Chip-Seq_Bcells_Human | 0.98996742 |
| 116 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98752266 |
| 117 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.98141596 |
| 118 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97664888 |
| 119 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.97661982 |
| 120 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.97411452 |
| 121 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.96308564 |
| 122 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95490419 |
| 123 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.92966407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004510_myositis | 3.68313368 |
| 2 | MP0003303_peritoneal_inflammation | 3.56899256 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.09385502 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.92208705 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 2.75853828 |
| 6 | MP0000569_abnormal_digit_pigmentation | 2.69110044 |
| 7 | MP0008961_abnormal_basal_metabolism | 2.67058200 |
| 8 | MP0009278_abnormal_bone_marrow | 2.49282248 |
| 9 | MP0008260_abnormal_autophagy | 2.25465975 |
| 10 | MP0005451_abnormal_body_composition | 2.18489652 |
| 11 | MP0003566_abnormal_cell_adhesion | 2.02113365 |
| 12 | MP0003724_increased_susceptibility_to | 2.01777747 |
| 13 | MP0004130_abnormal_muscle_cell | 1.97528893 |
| 14 | MP0004084_abnormal_cardiac_muscle | 1.97413489 |
| 15 | MP0005167_abnormal_blood-brain_barrier | 1.95575112 |
| 16 | MP0003172_abnormal_lysosome_physiology | 1.93019672 |
| 17 | MP0000751_myopathy | 1.91416987 |
| 18 | MP0000685_abnormal_immune_system | 1.88977674 |
| 19 | MP0002166_altered_tumor_susceptibility | 1.87245444 |
| 20 | MP0005058_abnormal_lysosome_morphology | 1.84894630 |
| 21 | MP0004808_abnormal_hematopoietic_stem | 1.75881494 |
| 22 | MP0001533_abnormal_skeleton_physiology | 1.71173738 |
| 23 | MP0001958_emphysema | 1.69550636 |
| 24 | MP0003045_fibrosis | 1.67145617 |
| 25 | MP0004185_abnormal_adipocyte_glucose | 1.66780564 |
| 26 | MP0010352_gastrointestinal_tract_polyps | 1.66364181 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.65969191 |
| 28 | MP0003075_altered_response_to | 1.64041454 |
| 29 | MP0005409_darkened_coat_color | 1.62387618 |
| 30 | MP0005397_hematopoietic_system_phenotyp | 1.61626908 |
| 31 | MP0001545_abnormal_hematopoietic_system | 1.61626908 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.50512865 |
| 33 | MP0005076_abnormal_cell_differentiation | 1.48771333 |
| 34 | MP0010234_abnormal_vibrissa_follicle | 1.45796413 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.45794031 |
| 36 | MP0003283_abnormal_digestive_organ | 1.45504916 |
| 37 | MP0002909_abnormal_adrenal_gland | 1.45267186 |
| 38 | MP0002396_abnormal_hematopoietic_system | 1.40945975 |
| 39 | MP0001835_abnormal_antigen_presentation | 1.40660740 |
| 40 | MP0002933_joint_inflammation | 1.40629074 |
| 41 | MP0000858_altered_metastatic_potential | 1.40072216 |
| 42 | MP0003453_abnormal_keratinocyte_physiol | 1.38296308 |
| 43 | MP0003091_abnormal_cell_migration | 1.37386763 |
| 44 | MP0001348_abnormal_lacrimal_gland | 1.34868230 |
| 45 | MP0000678_abnormal_parathyroid_gland | 1.33849922 |
| 46 | MP0001800_abnormal_humoral_immune | 1.33576910 |
| 47 | MP0006082_CNS_inflammation | 1.32489476 |
| 48 | MP0004036_abnormal_muscle_relaxation | 1.30928917 |
| 49 | MP0010630_abnormal_cardiac_muscle | 1.30162724 |
| 50 | MP0004858_abnormal_nervous_system | 1.29869819 |
| 51 | MP0004947_skin_inflammation | 1.28707223 |
| 52 | MP0004087_abnormal_muscle_fiber | 1.27955824 |
| 53 | MP0001790_abnormal_immune_system | 1.26937262 |
| 54 | MP0005387_immune_system_phenotype | 1.26937262 |
| 55 | MP0003436_decreased_susceptibility_to | 1.26205796 |
| 56 | MP0003279_aneurysm | 1.24945114 |
| 57 | MP0003879_abnormal_hair_cell | 1.24364234 |
| 58 | MP0005666_abnormal_adipose_tissue | 1.23481547 |
| 59 | MP0003828_pulmonary_edema | 1.22709798 |
| 60 | MP0010307_abnormal_tumor_latency | 1.21367119 |
| 61 | MP0002452_abnormal_antigen_presenting | 1.20617059 |
| 62 | MP0002822_catalepsy | 1.17733390 |
| 63 | MP0000604_amyloidosis | 1.17720039 |
| 64 | MP0003183_abnormal_peptide_metabolism | 1.17314574 |
| 65 | MP0002398_abnormal_bone_marrow | 1.17001549 |
| 66 | MP0005623_abnormal_meninges_morphology | 1.16706163 |
| 67 | MP0003635_abnormal_synaptic_transmissio | 1.16661398 |
| 68 | MP0002006_tumorigenesis | 1.16641937 |
| 69 | MP0000343_altered_response_to | 1.16367590 |
| 70 | MP0002837_dystrophic_cardiac_calcinosis | 1.15287589 |
| 71 | MP0003866_abnormal_defecation | 1.13787321 |
| 72 | MP0005375_adipose_tissue_phenotype | 1.12778386 |
| 73 | MP0002420_abnormal_adaptive_immunity | 1.12664002 |
| 74 | MP0009785_altered_susceptibility_to | 1.12539239 |
| 75 | MP0001819_abnormal_immune_cell | 1.10821168 |
| 76 | MP0001873_stomach_inflammation | 1.09388413 |
| 77 | MP0005023_abnormal_wound_healing | 1.08532020 |
| 78 | MP0000747_muscle_weakness | 1.07943829 |
| 79 | MP0002723_abnormal_immune_serum | 1.06401643 |
| 80 | MP0002249_abnormal_larynx_morphology | 1.06345071 |
| 81 | MP0005390_skeleton_phenotype | 1.06135222 |
| 82 | MP0002419_abnormal_innate_immunity | 1.05712830 |
| 83 | MP0000465_gastrointestinal_hemorrhage | 1.04124334 |
| 84 | MP0005000_abnormal_immune_tolerance | 1.03000404 |
| 85 | MP0006138_congestive_heart_failure | 1.02008966 |
| 86 | MP0003329_amyloid_beta_deposits | 1.00265186 |
| 87 | MP0005330_cardiomyopathy | 0.99769674 |
| 88 | MP0002089_abnormal_postnatal_growth/wei | 0.99742987 |
| 89 | MP0001851_eye_inflammation | 0.99730467 |
| 90 | MP0008874_decreased_physiological_sensi | 0.98530742 |
| 91 | MP0005166_decreased_susceptibility_to | 0.98462289 |
| 92 | MP0009840_abnormal_foam_cell | 0.97683540 |
| 93 | MP0008438_abnormal_cutaneous_collagen | 0.97540844 |
| 94 | MP0002877_abnormal_melanocyte_morpholog | 0.97532376 |
| 95 | MP0008569_lethality_at_weaning | 0.97344818 |
| 96 | MP0002148_abnormal_hypersensitivity_rea | 0.96966961 |
| 97 | MP0000689_abnormal_spleen_morphology | 0.95792178 |
| 98 | MP0002722_abnormal_immune_system | 0.95601233 |
| 99 | MP0000703_abnormal_thymus_morphology | 0.94603217 |
| 100 | MP0000716_abnormal_immune_system | 0.94116696 |
| 101 | MP0000733_abnormal_muscle_development | 0.93484023 |
| 102 | MP0002405_respiratory_system_inflammati | 0.93045097 |
| 103 | MP0009333_abnormal_splenocyte_physiolog | 0.93005871 |
| 104 | MP0008004_abnormal_stomach_pH | 0.91674709 |
| 105 | MP0005385_cardiovascular_system_phenoty | 0.90704916 |
| 106 | MP0001544_abnormal_cardiovascular_syste | 0.90704916 |
| 107 | MP0003448_altered_tumor_morphology | 0.87058339 |
| 108 | MP0000003_abnormal_adipose_tissue | 0.85527609 |
| 109 | MP0001845_abnormal_inflammatory_respons | 0.85299779 |
| 110 | MP0005671_abnormal_response_to | 0.84742561 |
| 111 | MP0005025_abnormal_response_to | 0.84372320 |
| 112 | MP0003763_abnormal_thymus_physiology | 0.83903749 |
| 113 | MP0002254_reproductive_system_inflammat | 0.83875444 |
| 114 | MP0003690_abnormal_glial_cell | 0.83645065 |
| 115 | MP0004484_altered_response_of | 0.83503776 |
| 116 | MP0000767_abnormal_smooth_muscle | 0.82768230 |
| 117 | MP0000920_abnormal_myelination | 0.82751258 |
| 118 | MP0010155_abnormal_intestine_physiology | 0.82365656 |
| 119 | MP0010368_abnormal_lymphatic_system | 0.82105931 |
| 120 | MP0002998_abnormal_bone_remodeling | 0.81922034 |
| 121 | MP0001849_ear_inflammation | 0.80819817 |
| 122 | MP0003634_abnormal_glial_cell | 0.80021746 |
| 123 | MP0002429_abnormal_blood_cell | 0.79718721 |
| 124 | MP0002925_abnormal_cardiovascular_devel | 0.79610555 |
| 125 | MP0005174_abnormal_tail_pigmentation | 0.79526902 |
| 126 | MP0005670_abnormal_white_adipose | 0.79503879 |
| 127 | MP0002106_abnormal_muscle_physiology | 0.77386819 |
| 128 | MP0000249_abnormal_blood_vessel | 0.77192662 |
| 129 | MP0000759_abnormal_skeletal_muscle | 0.76798114 |
| 130 | MP0009384_cardiac_valve_regurgitation | 0.75345135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebral aneurysm (HP:0004944) | 4.37863866 |
| 2 | Obstructive sleep apnea (HP:0002870) | 3.63459320 |
| 3 | Hyperacusis (HP:0010780) | 3.21510624 |
| 4 | Hemiplegia (HP:0002301) | 2.78628475 |
| 5 | Abnormality of the nasal mucosa (HP:0000433) | 2.76465711 |
| 6 | Aortic aneurysm (HP:0004942) | 2.74955851 |
| 7 | Distal upper limb amyotrophy (HP:0007149) | 2.71244455 |
| 8 | Upper limb amyotrophy (HP:0009129) | 2.71244455 |
| 9 | Broad face (HP:0000283) | 2.70251708 |
| 10 | Hematochezia (HP:0002573) | 2.67548933 |
| 11 | Dysmetric saccades (HP:0000641) | 2.64945122 |
| 12 | Broad metatarsal (HP:0001783) | 2.51542079 |
| 13 | Abnormality of macrophages (HP:0004311) | 2.51378150 |
| 14 | Distal lower limb muscle weakness (HP:0009053) | 2.47694303 |
| 15 | Aneurysm (HP:0002617) | 2.47081354 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 2.46582296 |
| 17 | Thin bony cortex (HP:0002753) | 2.46395397 |
| 18 | Cervical subluxation (HP:0003308) | 2.45880040 |
| 19 | Annular pancreas (HP:0001734) | 2.42770584 |
| 20 | Colitis (HP:0002583) | 2.40113940 |
| 21 | Mitral valve prolapse (HP:0001634) | 2.39175409 |
| 22 | Nasal polyposis (HP:0100582) | 2.37465244 |
| 23 | Polycythemia (HP:0001901) | 2.35316079 |
| 24 | Macroorchidism (HP:0000053) | 2.34771344 |
| 25 | Premature rupture of membranes (HP:0001788) | 2.29863482 |
| 26 | Bundle branch block (HP:0011710) | 2.29244794 |
| 27 | Hand muscle atrophy (HP:0009130) | 2.27424310 |
| 28 | Gingivitis (HP:0000230) | 2.25594960 |
| 29 | Supranuclear gaze palsy (HP:0000605) | 2.22181661 |
| 30 | Striae distensae (HP:0001065) | 2.21733625 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 2.21258735 |
| 32 | Lower limb amyotrophy (HP:0007210) | 2.21146916 |
| 33 | Long toe (HP:0010511) | 2.20709103 |
| 34 | Asymmetric septal hypertrophy (HP:0001670) | 2.19914903 |
| 35 | Insomnia (HP:0100785) | 2.19376413 |
| 36 | Papilledema (HP:0001085) | 2.19328378 |
| 37 | Increased density of long bones (HP:0006392) | 2.19324641 |
| 38 | Spontaneous hematomas (HP:0007420) | 2.19188364 |
| 39 | Axonal loss (HP:0003447) | 2.18822056 |
| 40 | Frequent falls (HP:0002359) | 2.17803189 |
| 41 | Vertebral compression fractures (HP:0002953) | 2.17674796 |
| 42 | Sudden death (HP:0001699) | 2.16978359 |
| 43 | Rapidly progressive (HP:0003678) | 2.16504165 |
| 44 | Neurofibrillary tangles (HP:0002185) | 2.15937539 |
| 45 | Visual hallucinations (HP:0002367) | 2.15701811 |
| 46 | Abnormality of the fingertips (HP:0001211) | 2.15370827 |
| 47 | Difficulty running (HP:0009046) | 2.15227143 |
| 48 | Eczematoid dermatitis (HP:0000976) | 2.14322133 |
| 49 | Abnormality of the lower motor neuron (HP:0002366) | 2.13659443 |
| 50 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.13528306 |
| 51 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.13528306 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.13528306 |
| 53 | Hemorrhage of the eye (HP:0011885) | 2.12866390 |
| 54 | Pointed chin (HP:0000307) | 2.12139997 |
| 55 | Stridor (HP:0010307) | 2.10481499 |
| 56 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.10272397 |
| 57 | Mucopolysacchariduria (HP:0008155) | 2.10272397 |
| 58 | Shallow orbits (HP:0000586) | 2.09871790 |
| 59 | Gastrointestinal inflammation (HP:0004386) | 2.08207216 |
| 60 | Myositis (HP:0100614) | 2.08198175 |
| 61 | Increased connective tissue (HP:0009025) | 2.07122577 |
| 62 | Nuclear cataract (HP:0100018) | 2.06831802 |
| 63 | Cellulitis (HP:0100658) | 2.06067096 |
| 64 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.05606735 |
| 65 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.05025473 |
| 66 | Abnormality of glycolipid metabolism (HP:0010969) | 2.05025473 |
| 67 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.05025473 |
| 68 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.04811988 |
| 69 | Increased IgE level (HP:0003212) | 2.04178940 |
| 70 | Cerebral inclusion bodies (HP:0100314) | 2.03795579 |
| 71 | Inflammation of the large intestine (HP:0002037) | 2.03455358 |
| 72 | Mitral regurgitation (HP:0001653) | 2.03006661 |
| 73 | Distal lower limb amyotrophy (HP:0008944) | 2.02546689 |
| 74 | Facial diplegia (HP:0001349) | 2.01793433 |
| 75 | Dilatation of the ascending aorta (HP:0005111) | 2.00482502 |
| 76 | Hyporeflexia of lower limbs (HP:0002600) | 1.99797229 |
| 77 | Malnutrition (HP:0004395) | 1.98817750 |
| 78 | Amyloidosis (HP:0011034) | 1.96317634 |
| 79 | Resting tremor (HP:0002322) | 1.93815910 |
| 80 | J-shaped sella turcica (HP:0002680) | 1.92464261 |
| 81 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.92087802 |
| 82 | Achilles tendon contracture (HP:0001771) | 1.91817062 |
| 83 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.90675904 |
| 84 | Enlarged penis (HP:0000040) | 1.90295707 |
| 85 | Absent frontal sinuses (HP:0002688) | 1.89765125 |
| 86 | Neuronal loss in central nervous system (HP:0002529) | 1.89663967 |
| 87 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.89578843 |
| 88 | Ulnar bowing (HP:0003031) | 1.89492693 |
| 89 | Neoplasm of the heart (HP:0100544) | 1.88262763 |
| 90 | Aortic dissection (HP:0002647) | 1.87946448 |
| 91 | Hypertriglyceridemia (HP:0002155) | 1.87927729 |
| 92 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.87683803 |
| 93 | Elfin facies (HP:0004428) | 1.87045546 |
| 94 | Lymphangioma (HP:0100764) | 1.86800614 |
| 95 | Peritonitis (HP:0002586) | 1.86723884 |
| 96 | Verrucae (HP:0200043) | 1.86163355 |
| 97 | Papilloma (HP:0012740) | 1.86163355 |
| 98 | Chronic obstructive pulmonary disease (HP:0006510) | 1.85582317 |
| 99 | Obstructive lung disease (HP:0006536) | 1.85582317 |
| 100 | Prolonged bleeding time (HP:0003010) | 1.84968680 |
| 101 | Difficulty climbing stairs (HP:0003551) | 1.84041881 |
| 102 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.83755562 |
| 103 | Metaphyseal cupping (HP:0003021) | 1.82204763 |
| 104 | Recurrent abscess formation (HP:0002722) | 1.82128575 |
| 105 | Orchitis (HP:0100796) | 1.81942263 |
| 106 | Ventricular fibrillation (HP:0001663) | 1.81055353 |
| 107 | Apathy (HP:0000741) | 1.81053194 |
| 108 | Gastrointestinal infarctions (HP:0005244) | 1.80934581 |
| 109 | Joint stiffness (HP:0001387) | 1.80912695 |
| 110 | Slow saccadic eye movements (HP:0000514) | 1.80653750 |
| 111 | Bowel diverticulosis (HP:0005222) | 1.80537091 |
| 112 | Impaired platelet aggregation (HP:0003540) | 1.79898088 |
| 113 | Abnormal platelet function (HP:0011869) | 1.79898088 |
| 114 | Fragile skin (HP:0001030) | 1.79659646 |
| 115 | Interstitial pulmonary disease (HP:0006530) | 1.79274153 |
| 116 | Abnormality of complement system (HP:0005339) | 1.78745559 |
| 117 | Biconcave vertebral bodies (HP:0004586) | 1.78690731 |
| 118 | Global brain atrophy (HP:0002283) | 1.78325421 |
| 119 | Heterotopia (HP:0002282) | 1.77937405 |
| 120 | Vertebral arch anomaly (HP:0008438) | 1.76905697 |
| 121 | Abnormality of the thoracic spine (HP:0100711) | 1.76805982 |
| 122 | Genu recurvatum (HP:0002816) | 1.76722548 |
| 123 | Increased variability in muscle fiber diameter (HP:0003557) | 1.76451868 |
| 124 | Thoracic kyphosis (HP:0002942) | 1.76237255 |
| 125 | Bicuspid aortic valve (HP:0001647) | 1.76192796 |
| 126 | Urinary urgency (HP:0000012) | 1.74843909 |
| 127 | Easy fatigability (HP:0003388) | 1.74706736 |
| 128 | Recurrent fungal infections (HP:0002841) | 1.74655153 |
| 129 | Muscle fiber splitting (HP:0003555) | 1.73494674 |
| 130 | Disproportionate tall stature (HP:0001519) | 1.72910144 |
| 131 | Blue sclerae (HP:0000592) | 1.72652040 |
| 132 | Chronic otitis media (HP:0000389) | 1.72068111 |
| 133 | Dysostosis multiplex (HP:0000943) | 1.71850742 |
| 134 | Spinal rigidity (HP:0003306) | 1.71414303 |
| 135 | Protrusio acetabuli (HP:0003179) | 1.70784759 |
| 136 | Hemangiomatosis (HP:0007461) | 1.70606220 |
| 137 | Gastrointestinal stroma tumor (HP:0100723) | 1.69615469 |
| 138 | Emphysema (HP:0002097) | 1.68727098 |
| 139 | Onion bulb formation (HP:0003383) | 1.68337984 |
| 140 | Atrophic scars (HP:0001075) | 1.68172891 |
| 141 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.68172564 |
| 142 | Arterial tortuosity (HP:0005116) | 1.67197810 |
| 143 | Abnormality of the Achilles tendon (HP:0005109) | 1.66215730 |
| 144 | Mediastinal lymphadenopathy (HP:0100721) | 1.66177103 |
| 145 | Visceral angiomatosis (HP:0100761) | 1.66055247 |
| 146 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.64902627 |
| 147 | Diminished motivation (HP:0000745) | 1.64895890 |
| 148 | Polygenic inheritance (HP:0010982) | 1.64664279 |
| 149 | Asymmetry of the thorax (HP:0001555) | 1.64268812 |
| 150 | Gastrointestinal dysmotility (HP:0002579) | 1.63575143 |
| 151 | Increased CSF protein (HP:0002922) | 1.63221644 |
| 152 | Hypercortisolism (HP:0001578) | 1.61846043 |
| 153 | Atrioventricular block (HP:0001678) | 1.61656157 |
| 154 | Recurrent bacterial skin infections (HP:0005406) | 1.61373019 |
| 155 | Loss of speech (HP:0002371) | 1.61201068 |
| 156 | Recurrent viral infections (HP:0004429) | 1.59750898 |
| 157 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.59363078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.72266777 |
| 2 | PKN2 | 3.49295127 |
| 3 | PRPF4B | 3.46484612 |
| 4 | EEF2K | 2.73117936 |
| 5 | TTN | 2.58121314 |
| 6 | SIK2 | 2.41459002 |
| 7 | MAP4K1 | 2.33133177 |
| 8 | MAP3K10 | 2.04306507 |
| 9 | RIPK1 | 1.97777888 |
| 10 | SMG1 | 1.92468444 |
| 11 | RIPK4 | 1.84787596 |
| 12 | TGFBR2 | 1.73727690 |
| 13 | IRAK3 | 1.72811407 |
| 14 | MAP3K11 | 1.68125554 |
| 15 | CAMK1G | 1.64902095 |
| 16 | MAP2K3 | 1.59044581 |
| 17 | KSR2 | 1.55113476 |
| 18 | CAMK1D | 1.54677230 |
| 19 | PTK6 | 1.54631103 |
| 20 | DMPK | 1.52751362 |
| 21 | CAMKK1 | 1.51603134 |
| 22 | MAP3K9 | 1.51014044 |
| 23 | PRKD3 | 1.48309009 |
| 24 | ALK | 1.46600613 |
| 25 | ERN1 | 1.45336360 |
| 26 | PRKCH | 1.44699028 |
| 27 | MAP3K7 | 1.43056698 |
| 28 | BLK | 1.41541166 |
| 29 | TAOK1 | 1.40985081 |
| 30 | TESK1 | 1.38278881 |
| 31 | FES | 1.35343698 |
| 32 | TAOK2 | 1.35035925 |
| 33 | DDR2 | 1.33557568 |
| 34 | DAPK2 | 1.27427932 |
| 35 | TYK2 | 1.24696425 |
| 36 | PRKD2 | 1.23909326 |
| 37 | GRK6 | 1.20579100 |
| 38 | CDK12 | 1.19503321 |
| 39 | HCK | 1.16829050 |
| 40 | PDGFRA | 1.14206955 |
| 41 | JAK1 | 1.14006112 |
| 42 | FGFR3 | 1.12003137 |
| 43 | MAP3K6 | 1.11755528 |
| 44 | RET | 1.11750922 |
| 45 | IRAK4 | 1.10631212 |
| 46 | KIT | 1.09503308 |
| 47 | EPHB1 | 1.08708295 |
| 48 | ICK | 1.07402337 |
| 49 | LRRK2 | 1.06272959 |
| 50 | TYRO3 | 1.03118869 |
| 51 | BMX | 0.99601470 |
| 52 | MAP3K13 | 0.98252199 |
| 53 | LMTK2 | 0.96262435 |
| 54 | PAK6 | 0.95365258 |
| 55 | ZAP70 | 0.94946197 |
| 56 | PDK1 | 0.94536150 |
| 57 | PTK2B | 0.92992414 |
| 58 | TBK1 | 0.92699539 |
| 59 | MARK2 | 0.91699240 |
| 60 | RPS6KL1 | 0.88921447 |
| 61 | SCYL2 | 0.85740430 |
| 62 | STK38 | 0.85687741 |
| 63 | JAK2 | 0.85123888 |
| 64 | TNK2 | 0.84984852 |
| 65 | SIK1 | 0.84827396 |
| 66 | SGK3 | 0.84042053 |
| 67 | PDPK1 | 0.80577252 |
| 68 | FGFR4 | 0.78221107 |
| 69 | MAP3K14 | 0.77739862 |
| 70 | JAK3 | 0.77690962 |
| 71 | PAK2 | 0.76328847 |
| 72 | IRAK2 | 0.74151883 |
| 73 | EPHA4 | 0.73802015 |
| 74 | PRKD1 | 0.73787211 |
| 75 | MTOR | 0.73616877 |
| 76 | CAMK4 | 0.73577424 |
| 77 | PRKG2 | 0.73448693 |
| 78 | STK11 | 0.72633989 |
| 79 | SYK | 0.72291683 |
| 80 | NTRK3 | 0.72245166 |
| 81 | ARAF | 0.70461727 |
| 82 | MYLK | 0.70458788 |
| 83 | TIE1 | 0.69037692 |
| 84 | PDGFRB | 0.68059650 |
| 85 | CSF1R | 0.66713385 |
| 86 | CDC42BPA | 0.66540443 |
| 87 | MAPK7 | 0.66182528 |
| 88 | STK10 | 0.65141861 |
| 89 | SIK3 | 0.65124822 |
| 90 | CSK | 0.65000541 |
| 91 | BTK | 0.64643673 |
| 92 | RPS6KA2 | 0.64413040 |
| 93 | PTK2 | 0.64222247 |
| 94 | FGR | 0.61662980 |
| 95 | ITK | 0.59887471 |
| 96 | NEK2 | 0.59441686 |
| 97 | MAP3K1 | 0.59006969 |
| 98 | PAK4 | 0.59003061 |
| 99 | MAP3K2 | 0.58278161 |
| 100 | CAMK1 | 0.57067180 |
| 101 | MAPKAPK3 | 0.56493850 |
| 102 | NME2 | 0.55102826 |
| 103 | DAPK1 | 0.53440464 |
| 104 | CDK6 | 0.52231684 |
| 105 | MOS | 0.52180627 |
| 106 | MARK3 | 0.49635845 |
| 107 | KDR | 0.49554983 |
| 108 | MAPK4 | 0.49552717 |
| 109 | DAPK3 | 0.49544615 |
| 110 | MAP2K6 | 0.49406241 |
| 111 | CDK4 | 0.49382807 |
| 112 | MST1R | 0.49157778 |
| 113 | NTRK1 | 0.48410022 |
| 114 | HIPK2 | 0.47987283 |
| 115 | INSRR | 0.47019925 |
| 116 | UHMK1 | 0.46973365 |
| 117 | MAPK12 | 0.46298825 |
| 118 | IKBKE | 0.46049050 |
| 119 | LCK | 0.45624427 |
| 120 | MAP2K2 | 0.44790546 |
| 121 | MAPK11 | 0.44350318 |
| 122 | ILK | 0.43540957 |
| 123 | CDK5 | 0.43405479 |
| 124 | CAMKK2 | 0.43328857 |
| 125 | LATS2 | 0.43293431 |
| 126 | FYN | 0.41570974 |
| 127 | MAP3K3 | 0.41201202 |
| 128 | DYRK1B | 0.41119303 |
| 129 | RPS6KA6 | 0.40766947 |
| 130 | RPS6KC1 | 0.39455535 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.52547582 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.78846079 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.70819647 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.62144601 |
| 5 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.51226453 |
| 6 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.50660202 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.48477308 |
| 8 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.42819520 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 1.42389165 |
| 10 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.41109130 |
| 11 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.36697079 |
| 12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35018094 |
| 13 | Platelet activation_Homo sapiens_hsa04611 | 1.34114949 |
| 14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.33544727 |
| 15 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.32473489 |
| 16 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.30896715 |
| 17 | Glioma_Homo sapiens_hsa05214 | 1.30642742 |
| 18 | Long-term potentiation_Homo sapiens_hsa04720 | 1.29932508 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.29931383 |
| 20 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.29528187 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.28967162 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.28379283 |
| 23 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.28336216 |
| 24 | Prion diseases_Homo sapiens_hsa05020 | 1.26561536 |
| 25 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.26366441 |
| 26 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.24981530 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.23795908 |
| 28 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.23372092 |
| 29 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.22214587 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.18399565 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17006826 |
| 32 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.14772567 |
| 33 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.14412586 |
| 34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.13163522 |
| 35 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.12846253 |
| 36 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.12071396 |
| 37 | Salivary secretion_Homo sapiens_hsa04970 | 1.11722413 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.09121890 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08241338 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.07198468 |
| 41 | Insulin resistance_Homo sapiens_hsa04931 | 1.06883737 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06574520 |
| 43 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.05427900 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.05009914 |
| 45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.04253740 |
| 46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.03896590 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02360008 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.02098183 |
| 49 | Bladder cancer_Homo sapiens_hsa05219 | 1.02014853 |
| 50 | Circadian entrainment_Homo sapiens_hsa04713 | 1.00327075 |
| 51 | * Focal adhesion_Homo sapiens_hsa04510 | 0.99107069 |
| 52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.99013650 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.98972386 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98191666 |
| 55 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.97621040 |
| 56 | Endocytosis_Homo sapiens_hsa04144 | 0.96708420 |
| 57 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.94454193 |
| 58 | Morphine addiction_Homo sapiens_hsa05032 | 0.93690596 |
| 59 | Amoebiasis_Homo sapiens_hsa05146 | 0.93241583 |
| 60 | Influenza A_Homo sapiens_hsa05164 | 0.92808248 |
| 61 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.92648303 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 0.91244170 |
| 63 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.90988790 |
| 64 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.89990281 |
| 65 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.88838736 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88165408 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.87593779 |
| 68 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.87269423 |
| 69 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.87247138 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86728469 |
| 71 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.86561363 |
| 72 | Gap junction_Homo sapiens_hsa04540 | 0.85820939 |
| 73 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.85730098 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.85279556 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85160432 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.84922738 |
| 77 | Endometrial cancer_Homo sapiens_hsa05213 | 0.84543746 |
| 78 | Tuberculosis_Homo sapiens_hsa05152 | 0.84143127 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84132371 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84038247 |
| 81 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.83925702 |
| 82 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82744640 |
| 83 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.81885868 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.81799538 |
| 85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.80111119 |
| 86 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.79441526 |
| 87 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.79348514 |
| 88 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.77012959 |
| 89 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.76527977 |
| 90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.76042260 |
| 91 | Lysine degradation_Homo sapiens_hsa00310 | 0.75685060 |
| 92 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73892064 |
| 93 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.73751752 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73152933 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72907898 |
| 96 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.72332532 |
| 97 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72093199 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71908836 |
| 99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.70946301 |
| 100 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70720248 |
| 101 | Allograft rejection_Homo sapiens_hsa05330 | 0.70047056 |
| 102 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.69857161 |
| 103 | Insulin secretion_Homo sapiens_hsa04911 | 0.69270103 |
| 104 | Phagosome_Homo sapiens_hsa04145 | 0.69019490 |
| 105 | Salmonella infection_Homo sapiens_hsa05132 | 0.68546053 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68335952 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.67850070 |
| 108 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.67573718 |
| 109 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.67104234 |
| 110 | Shigellosis_Homo sapiens_hsa05131 | 0.66965130 |
| 111 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.66697395 |
| 112 | Cocaine addiction_Homo sapiens_hsa05030 | 0.66301600 |
| 113 | Colorectal cancer_Homo sapiens_hsa05210 | 0.65850619 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65341661 |
| 115 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63784984 |
| 116 | Apoptosis_Homo sapiens_hsa04210 | 0.63697804 |
| 117 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.63471994 |
| 118 | Hepatitis B_Homo sapiens_hsa05161 | 0.62930410 |
| 119 | Measles_Homo sapiens_hsa05162 | 0.60471046 |
| 120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60195938 |
| 121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59720915 |
| 122 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.59164873 |
| 123 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.57489935 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56881519 |
| 125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56464270 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56092564 |
| 127 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54552092 |
| 128 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.52793326 |

